US and EU patent offices invalidate Immunex’ patents claiming antibodi – The Pharma Letter

US and EU patent offices invalidate Immunex’ patents claiming antibodi  The Pharma Letter

Regeneron Pharmaceuticals (Nasdaq: REGN) has announced two important legal developments invalidating Immunex patents with functional claims to …